Skip to content

Inspection Record

Biomat USA, Inc. — FDA 483 Findings

US FDAInspected 2025-01-09Published 2026-10-20 4 findingsEquipment and facilityMaterial and supplier controlDeviation, CAPA, and investigation

Inspectors Emily B CamireThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

Failure of equipment to perform in the manner for which it was designed so as to assure compliance with the official requirements prescribed in 21 CFR 606.

2Material and supplier control

Written standard operating procedures including all steps to be followed in the collection of blood and blood components for further manufacturing purposes were not always established.

3Material and supplier control

Records are not concurrently maintained with the performance of each significant step in the collection of each unit of blood and blood components so that all steps can be clearly traced.

4Deviation, CAPA, and investigation

Failure to perform a thorough investigation of an unexplained discrepancy anda failure of a lot or unit to meet any of its specifications.

A record as of the US FDA document published on 2026-10-20. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Other records for this company

Biomat USA, Inc. findings history — including this company's other documentsAll US FDA findings US FDA documents, 2026 Go to Findings search
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.